|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for PFKL |
Basic gene info. | Gene symbol | PFKL |
Gene name | phosphofructokinase, liver | |
Synonyms | ATP-PFK|PFK-B|PFK-L | |
Cytomap | UCSC genome browser: 21q22.3 | |
Genomic location | chr21 :45719929-45747256 | |
Type of gene | protein-coding | |
RefGenes | NM_001002021.2, NM_002626.5,NR_024108.1, | |
Ensembl id | ENSG00000141959 | |
Description | 6-phosphofructokinase type B6-phosphofructokinase, liver typeATP-PFKATP-dependent 6-phosphofructokinase, liver typeliver-type 1-phosphofructokinasephosphofructo-1-kinase isozyme Bphosphohexokinase | |
Modification date | 20141207 | |
dbXrefs | MIM : 171860 | |
HGNC : HGNC | ||
Ensembl : ENSG00000141959 | ||
HPRD : 01385 | ||
Vega : OTTHUMG00000086910 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_PFKL | |
BioGPS: 5211 | ||
Gene Expression Atlas: ENSG00000141959 | ||
The Human Protein Atlas: ENSG00000141959 | ||
Pathway | NCI Pathway Interaction Database: PFKL | |
KEGG: PFKL | ||
REACTOME: PFKL | ||
ConsensusPathDB | ||
Pathway Commons: PFKL | ||
Metabolism | MetaCyc: PFKL | |
HUMANCyc: PFKL | ||
Regulation | Ensembl's Regulation: ENSG00000141959 | |
miRBase: chr21 :45,719,929-45,747,256 | ||
TargetScan: NM_001002021 | ||
cisRED: ENSG00000141959 | ||
Context | iHOP: PFKL | |
cancer metabolism search in PubMed: PFKL | ||
UCL Cancer Institute: PFKL | ||
Assigned class in ccmGDB | C |
Top |
Phenotypic Information for PFKL(metabolism pathway, cancer, disease, phenome) |
![]() | |
Cancer | CGAP: PFKL |
Familial Cancer Database: PFKL |
* This gene is included in those cancer gene databases. |
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
![]() | |
KEGG_GLYCOLYSIS_GLUCONEOGENESIS KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM KEGG_GALACTOSE_METABOLISM BIOCARTA_GLYCOLYSIS_PATHWAY REACTOME_METABOLISM_OF_CARBOHYDRATES REACTOME_GLUCOSE_METABOLISM |
![]() | |
OMIM | |
Orphanet | |
Disease | KEGG Disease: PFKL |
MedGen: PFKL (Human Medical Genetics with Condition) | |
ClinVar: PFKL | |
Phenotype | MGI: PFKL (International Mouse Phenotyping Consortium) |
PhenomicDB: PFKL |
Mutations for PFKL |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
![]() |
There's no structural variation information in COSMIC data for this gene. |
![]() |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows PFKL related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
BI060191 | PFKL | 1 | 100 | 21 | 45732161 | 45732943 | PFKL | 93 | 477 | 21 | 45745073 | 45746701 | |
AF086180 | TPI1 | 1 | 88 | 12 | 6979877 | 6979964 | PFKL | 83 | 322 | 21 | 45747008 | 45747247 | |
DB010470 | PFKL | 1 | 307 | 21 | 45719959 | 45732023 | NFKB2 | 297 | 318 | 10 | 104156504 | 104156526 | |
BI024780 | PFKL | 16 | 176 | 21 | 45732037 | 45732881 | PFKL | 171 | 503 | 21 | 45745859 | 45746739 |
![]() |
Top |
![]() |
There's no copy number variation information in COSMIC data for this gene. |
Top |
![]() |
|
![]() |
Top |
![]() |
Stat. for Non-Synonymous SNVs (# total SNVs=48) | (# total SNVs=21) |
![]() | ![]() |
(# total SNVs=2) | (# total SNVs=0) |
![]() |
Top |
![]() |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr21:45732012-45732012 | p.R135C | 3 |
chr21:45725724-45725724 | p.F44L | 3 |
chr21:45736214-45736214 | p.V326L | 2 |
chr21:45743748-45743748 | p.P580S | 2 |
chr21:45725780-45725780 | p.S63* | 2 |
chr21:45736395-45736395 | p.F355F | 2 |
chr21:45732116-45732116 | p.L169L | 2 |
chr21:45739290-45739290 | p.L420L | 2 |
chr21:45746069-45746069 | p.S753L | 2 |
chr21:45732008-45732008 | p.S133S | 2 |
Top |
![]() |
|
![]() |
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 2 | 2 | 1 | 6 | 2 |   | 3 |   | 2 | 3 |   | 13 | 1 |   |   |   | 6 | 6 |   | 6 |
# mutation | 2 | 2 | 1 | 6 | 2 |   | 3 |   | 2 | 3 |   | 15 | 1 |   |   |   | 6 | 8 |   | 8 |
nonsynonymous SNV |   |   |   | 4 | 1 |   | 3 |   | 2 | 1 |   | 7 | 1 |   |   |   | 3 | 6 |   | 7 |
synonymous SNV | 2 | 2 | 1 | 2 | 1 |   |   |   |   | 2 |   | 8 |   |   |   |   | 3 | 2 |   | 1 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
![]() |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr21:45741733 | p.M322I,PFKL | 1 |
chr21:45732045 | p.V494M,PFKL | 1 |
chr21:45736321 | p.K749N,PFKL | 1 |
chr21:45745112 | p.D173D,PFKL | 1 |
chr21:45738472 | p.D330N,PFKL | 1 |
chr21:45741738 | p.V495V,PFKL | 1 |
chr21:45732884 | p.A760T,PFKL | 1 |
chr21:45736372 | p.R184L,PFKL | 1 |
chr21:45745850 | p.V335M,PFKL | 1 |
chr21:45739290 | p.I524I,PFKL | 1 |
![]() |
![]() |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
![]() |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for PFKL |
![]() |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
![]() |
![]() |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
![]() |
Top |
![]() |
* This plots show the correlation between CNV and gene expression. |
![]() | |
![]() |
Top |
Gene-Gene Network Information |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
![]() | |
ADCK5,ATAD3A,C21orf33,FAM207A,GUK1,INTS1,MAD1L1, NTMT1,NCLN,PFKL,PWP2,RRP1,SCYL1,SLC19A1, SUMO3,TCF25,TRPM2,U2AF1,VARS,WDR4,WDR46 | AAMP,AKT1,ALDH16A1,ATAD3A,BRAT1,NELFB,CORO1B, GIPC1,HGS,LRPAP1,NCLN,OSBPL5,PFKL,PNKP, SCAF1,SDF4,SLC4A2,SPHK2,STRN4,TMEM129,UNC45A |
![]() | |
ACADS,AGPAT3,BDH1,C21orf2,C21orf33,FAM207A,CC2D1A, CPSF3L,ELMO3,FBXW5,ICOSLG,LSS,MCM3AP,NCKIPSD, NDUFV1,PFKL,PWP2,RPS6KA1,RRP1,SLC19A1,UQCRC1 | ACADS,SOWAHB,CBLC,CYB561A3,EPN1,ERBB2,ERBB3, CPTP,GPN2,KIAA1522,MGAT4B,C8orf82,MPND,MYO1D, PFKL,PTPRF,RNPEPL1,TMC4,TMEM102,ZBED1,ZNF784 |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
![]() |
Top |
Pharmacological Information for PFKL |
There's no related Drug. |
Top |
Cross referenced IDs for PFKL |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |